The excretion of 17-ketosteroids in patients suffering from mastopathia fibrocystica and mammary carcinomas.
Arch Geschwulstforsch
; 45(7): 648-57, 1975.
Article
en En
| MEDLINE
| ID: mdl-132149
Comparative investigations of the urinary excretion of different 17-ketosteroids in healthy women and patients suffering from mastopathia fibrocystica and/or mammary carcinomas had the following results: 1. A clear age dependency of the excretion of 17 ketosteroids during the regenerative period has been shown in all groups investigated, but it could not be observed during the postmenopausal phase. 2. There are no hints by the excretion values for a remarkable contribution of mammary carcinomas to the hormone metabolism of the host. 3. The excretion values of patients suffering from mastopathia fibrocystica confirm epidemiological results, which consider this from of mastopathia a precancerous one.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades de la Mama
/
Neoplasias de la Mama
/
Quistes
/
17-Cetosteroides
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Arch Geschwulstforsch
Año:
1975
Tipo del documento:
Article
Pais de publicación:
Alemania